ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Fluvoxamine for Adults With Mild to Moderate COVID-19

Asan Medical Center · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
severe acute respiratory syndrome coronavirus 2, coronavirus infection, mild to moderate covid-19, fluvoxamine, sars-cov-2 treatment, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 858210
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.